Jackson Creek Investment Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-36,021
Closed -$992K 356
2021
Q2
$992K Sell
36,021
-5,481
-13% -$108K 0.37% 144
2021
Q1
$684K Sell
41,502
-1,231
-3% -$28K 0.24% 208
2020
Q4
$788K Buy
+42,733
New +$765K 0.31% 181

Jackson Creek Investment Advisors's TBIO Position: Q3 2021 in Review

Jackson Creek Investment Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 36,021 shares — an estimated $992K sold.

Jackson Creek Investment Advisors first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $992K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Jackson Creek Investment Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 36,021 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $992K.
  • Jackson Creek Investment Advisors first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Jackson Creek Investment Advisors's Translate Bio, Inc. Common Stock position peaked at $992K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Jackson Creek Investment Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.